STOCK TITAN

Quest Diagnostics SVP Deppe sells 11,776 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Quest Diagnostics (DGX) SVP, Corp. Controller & CAO Michael J. Deppe exercised non-qualified stock options on November 13, 2026: 6,261 at $95.795 per share and 5,515 at $103.57 per share. He sold corresponding lots of 6,261 and 5,515 common shares at $260.17 per share under a Rule 10b5-1 sales plan adopted by him. A separate entry lists 713 shares indirectly through the company’s 401(k) plan; the reported figure is based on the plan’s stock-fund account balance, which includes some money market instruments.

Insider Deppe Michael J
Role SVP, Corp. Controller & CAO
Sold 11,776 shs ($3.06M)
Approx. gross sale proceeds $3.06M
Approx. exercise cost $1.17M
Approx. pre-tax spread $1.89M
Type Security Shares Price Value
Exercise Non-Qualifed Stock Option (right to buy) F1, F4 6,261 $95.795 $600K
Exercise Non-Qualifed Stock Option (right to buy) F1, F4 5,515 $103.57 $571K
Exercise Common Stock F1 6,261 $95.795 $600K
Sale Common Stock F1 6,261 $260.17 $1.63M
Exercise Common Stock F1 5,515 $103.57 $571K
Sale Common Stock F1, F2 5,515 $260.17 $1.43M
Holding Common Stock F3 -- -- --
Holdings After Transaction: Non-Qualifed Stock Option (right to buy) — 0 options (Direct); Common Stock — 35,203 shares (Direct); Common Stock — 713 shares (Indirect, 401(k))
Footnotes (4)
  1. F1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
  2. F2. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
  3. F3. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
  4. F4. The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
Options exercised, first tranche 6,261 options At $95.795 per share on November 13, 2026.
Options exercised, second tranche 5,515 options At $103.57 per share on November 13, 2026.
Common shares sold 11,776 shares Sold at $260.17 per share on November 13, 2026.
401(k) plan shares 713 shares Indirect holding entry based on the plan stock-fund account balance, which includes some money market instruments.
Rule 10b5-1 sales plan regulatory
"exercise and sale were effected pursuant to a Rule 10b5-1 sales plan"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DGX shares did SVP Michael J. Deppe sell, and at what price?

Michael J. Deppe sold 11,776 shares at $260.17 per share on November 13, 2026. The sales were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

What options did DGX SVP Michael J. Deppe exercise?

On November 13, 2026, Deppe exercised 6,261 non-qualified stock options at $95.795 per share and 5,515 at $103.57 per share. He sold corresponding lots of common shares at $260.17 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Deppe Michael J

(Last)(First)(Middle)
500 PLAZA DRIVE

(Street)
SECAUCUS NEW JERSEY 07094

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
QUEST DIAGNOSTICS INC [ DGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Corp. Controller & CAO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/13/2026M(1)6,261A$95.79541,464D
Common Stock11/13/2026S(1)6,261D$260.1735,203D
Common Stock11/13/2026M(1)5,515A$103.5740,718D
Common Stock11/13/2026S(1)5,515D$260.1735,203(2)D
Common Stock713(3)I401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualifed Stock Option (right to buy)$95.79511/13/2026M(1)6,261 (4)02/21/2027Common Stock6,261$95.7950D
Non-Qualifed Stock Option (right to buy)$103.5711/13/2026M(1)5,515 (4)02/19/2028Common Stock5,515$103.570D
Explanation of Responses:
1. This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
2. The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
3. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
4. The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
Remarks:
Sean D. Mersten, Attorney in Fact for Michael J. Deppe11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading